SEC Rule 10b-5

SHARHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lumen Technologies, Inc. f/k/a CenturyLink, Inc. of Class Action Lawsuit and Upcoming Deadline – LUMN

Retrieved on: 
Monday, November 13, 2023

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.

Key Points: 
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • The Company was formerly known as “CenturyLink, Inc.” and changed its name to “Lumen Technologies, Inc.” in September 2020.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Outlook Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – OTLK

Retrieved on: 
Monday, November 13, 2023

NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Outlook Therapeutics, Inc. (“Outlook” or the “Company”) (NASDAQ: OTLK) and certain officers.

Key Points: 
  • NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Outlook Therapeutics, Inc. (“Outlook” or the “Company”) (NASDAQ: OTLK) and certain officers.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Outlook is a late clinical-stage biopharmaceutical company that focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses in their Investment in Farfetch Limited of Class Action Lawsuit and Upcoming Deadline – FTCH

Retrieved on: 
Monday, November 13, 2023

NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Farfetch Limited (“Farfetch” or the “Company”) (NYSE: FTCH) and certain officers.

Key Points: 
  • NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Farfetch Limited (“Farfetch” or the “Company”) (NYSE: FTCH) and certain officers.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • In May 2023, Farfetch announced the commercial launch of its European partnership with footwear and clothing brand Reebok International Limited (“Reebok”).
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Nikola Corporation of Class Action Lawsuit and Upcoming Deadline – NKLA

Retrieved on: 
Monday, November 13, 2023

NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Nikola Corporation (“Nikola” or the “Company”) (NASDAQ: NKLA) and certain officers.

Key Points: 
  • NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Nikola Corporation (“Nikola” or the “Company”) (NASDAQ: NKLA) and certain officers.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in DLocal Limited of Class Action Lawsuit and Upcoming Deadline – DLO

Retrieved on: 
Monday, November 13, 2023

NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against DLocal Limited (“DLocal” or the “Company”) (NASDAQ: DLO) and certain officers.

Key Points: 
  • NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against DLocal Limited (“DLocal” or the “Company”) (NASDAQ: DLO) and certain officers.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • DLocal operates a payment processing platform for merchants worldwide and, as part of its operations, engages in certain foreign exchange transactions.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Summary Notice of Pendency of Class Action

Retrieved on: 
Thursday, November 30, 2023

2:21-cv-00675, has been certified by the Court as a class action on behalf of the Class defined above.

Key Points: 
  • 2:21-cv-00675, has been certified by the Court as a class action on behalf of the Class defined above.
  • IF YOU ARE A CLASS MEMBER, YOUR RIGHTS WILL BE AFFECTED BY THIS ACTION.
  • A Postcard Notice is currently being mailed to known potential Class Members.
  • If you have not received a Postcard Notice, you may obtain a copy of it or the long-form Notice by downloading them from Class Counsel’s website at www.bespc.com/cases/InstadosePharma-SecuritiesLitigation or contacting the Administrator at:

Rosen Law Firm Announces the Reopening of the Lead Plaintiff Appointment Process in a Class Action Against Axsome Therapeutics, Inc. and Certain Officers – AXSM

Retrieved on: 
Friday, November 17, 2023

Rosen Law Firm announces the reopening of the lead plaintiff appointment process in a class action lawsuit against Axsome Therapeutics, Inc. (“Axsome” or the “Company”) (NASDAQ: AXSM) and certain of its officers.

Key Points: 
  • Rosen Law Firm announces the reopening of the lead plaintiff appointment process in a class action lawsuit against Axsome Therapeutics, Inc. (“Axsome” or the “Company”) (NASDAQ: AXSM) and certain of its officers.
  • Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.

SHARHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lumen Technologies, Inc. f/k/a CenturyLink, Inc. of Class Action Lawsuit and Upcoming Deadline – LUMN

Retrieved on: 
Sunday, November 5, 2023

To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.

Key Points: 
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • The Company was formerly known as “CenturyLink, Inc.” and changed its name to “Lumen Technologies, Inc.” in September 2020.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Medical Properties Trust, Inc. of Class Action Lawsuit and Upcoming Deadline – MPW

Retrieved on: 
Sunday, November 5, 2023

NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Medical Properties Trust, Inc. (“MPW” or the “Company”) (NYSE: MPW) and certain officers.

Key Points: 
  • NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Medical Properties Trust, Inc. (“MPW” or the “Company”) (NYSE: MPW) and certain officers.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • MPW is a self-advised real estate investment trust that was formed to acquire and develop net-leased healthcare facilities.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in DLocal Limited of Class Action Lawsuit and Upcoming Deadline – DLO

Retrieved on: 
Sunday, November 5, 2023

NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against DLocal Limited (“DLocal” or the “Company”) (NASDAQ: DLO) and certain officers.

Key Points: 
  • NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against DLocal Limited (“DLocal” or the “Company”) (NASDAQ: DLO) and certain officers.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • DLocal operates a payment processing platform for merchants worldwide and, as part of its operations, engages in certain foreign exchange transactions.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.